Research Tracker›Biomarker Atlas›PACVS›Spike in neurological tissue

Spike in neurological tissue in PACVS

Spike in neurological tissue, also described as Post-vaccine neurological AE, is a spike antigen marker reported as elevated in PACVS (PACVS, PCVS) when patients are compared with healthy controls. The cited literature links this alteration to neurological complications. This entry summarises Ota et al. 2025. Group-level associations like this do not translate into an individual diagnostic cut-off.

↑ ElevatedSpike Antigen

Summary

Direction in PACVS↑ Elevated — higher than in the comparison group
CategorySpike Antigen
Also described asPost-vaccine neurological AE
Compared againstHC (healthy controls)
Associated symptomsNeurological complications
Test typeClinical or physiological test
SourceOta et al. 2025 — doi:10.1016/j.jocn.2025.111223
Condition atlasPACVS Biomarker Atlas

Related Spike Antigen markers in PACVS

Full list: PACVS Biomarker Atlas.

Frequently asked questions

Is Spike in neurological tissue high or low in PACVS?

Elevated. Studies summarised in the OSMF atlas report higher Spike in neurological tissue in PACVS than in healthy controls. Source: Ota et al. 2025.

What symptoms is Spike in neurological tissue associated with in PACVS?

The cited literature associates this marker with Neurological complications. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Spike in neurological tissue?

It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal Spike in neurological tissue result diagnostic of PACVS?

No. No single biomarker is diagnostic of PACVS. Spike in neurological tissue findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Spike in neurological tissue in PACVS: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/pacvs/spike-in-neurological-tissue.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-30 · Page generated from pacvs.json · Browse: PACVS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.